Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and 18F-FDG PET
Y Iizuka, Y Matsuo, S Umeoka, Y Nakamoto… - European journal of …, 2014 - Elsevier
Purpose/objectives To evaluate the use of diffusion-weighted magnetic resonance imaging
(DW-MRI) and 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for …
(DW-MRI) and 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for …
Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid 18F‐fluorodeoxyglucose‐positron …
Introduction Stereotactic ablative radiotherapy (SABR) is a guideline‐recommended
treatment for inoperable stage I non‐small cell lung cancer (NSCLC), but imaging …
treatment for inoperable stage I non‐small cell lung cancer (NSCLC), but imaging …
[引用][C] FDG PET response by 3 months following stereotactic body radiotherapy for non-small cell lung cancer may be an early surrogate of local failure
Results The post-SBRT PET scan was obtained at∼ 3 months following treatment (range 2
to 6 months). At a median follow up of 16 months (range 3 months to 33 months), 3 local …
to 6 months). At a median follow up of 16 months (range 3 months to 33 months), 3 local …
[HTML][HTML] The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy …
Introduction Stereotactic body radiation therapy (SBRT) is the standard of care treatment for
nonsurgical patients with early-stage non-small cell lung cancer (NSCLC). A recent report …
nonsurgical patients with early-stage non-small cell lung cancer (NSCLC). A recent report …
[HTML][HTML] Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local …
F Na, J Wang, C Li, L Deng, J Xue, Y Lu - Journal of Thoracic Oncology, 2014 - Elsevier
Introduction: The 2-[18F]-Fluorodeoxyglucose (FDG) positron emission tomography
(PET/CT) has become an imaging tool for clinical assessment of tumor, node, metastasis in …
(PET/CT) has become an imaging tool for clinical assessment of tumor, node, metastasis in …
[HTML][HTML] Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy …
S Zhang, S Li, Y Pei, M Huang, F Lu… - Journal of Thoracic …, 2017 - ncbi.nlm.nih.gov
Background The retrospective study investigated the association between the maximum
standardized uptake value (SUV max) of primary tumor and lymph node involvement in …
standardized uptake value (SUV max) of primary tumor and lymph node involvement in …
Patterns of pretreatment diagnostic assessment in patients treated with stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC): special …
FNOJ Habermann, D Schmitt, T Failing, J Fischer… - Current …, 2022 - mdpi.com
The pandemic raised a discussion about the postponement of medical interventions for non-
small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic …
small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic …
Update of a prospective study of stereotactic body radiation therapy for post-chemoradiation residual disease in stage II/III non-small cell lung cancer
S Kumar, J Feddock, X Li, AJ Shearer, L Hall… - International Journal of …, 2017 - Elsevier
Purpose To report long-term outcomes (risk of late toxicities, local control, and survival) of
dose escalation by stereotactic radiation therapy boost to residual fluorodeoxyglucose …
dose escalation by stereotactic radiation therapy boost to residual fluorodeoxyglucose …
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
DJ Hoopes, M Tann, JW Fletcher, JA Forquer, PF Lin… - Lung cancer, 2007 - Elsevier
PURPOSE: To investigate the utility of positron emission tomography (PET) in patients
treated with stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer …
treated with stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer …